NUCLEAR MEDICINE AND BIOLOGY
Scope & Guideline
Pioneering research at the intersection of medicine and biology.
Introduction
Aims and Scopes
- Development of Radiopharmaceuticals:
The journal emphasizes research on the synthesis, optimization, and characterization of radiopharmaceuticals, including novel agents for imaging and therapy. - Molecular Imaging Techniques:
There is a strong focus on the advancement of imaging modalities such as PET, SPECT, and hybrid imaging techniques, which are critical for diagnosing and monitoring diseases. - Theranostics:
The integration of diagnostic and therapeutic applications, particularly in the context of targeted radiotherapy and personalized medicine, is a core area of exploration. - Radiochemistry Innovations:
Research that explores new radiochemical methodologies, including novel labeling techniques and automation of synthesis processes, is a significant aspect of the journal. - Preclinical and Clinical Applications:
The journal publishes studies that bridge the gap between laboratory research and clinical applications, showcasing the translational potential of nuclear medicine. - Biomarker Development:
The identification and evaluation of biomarkers for various diseases, particularly cancer, through imaging and radiolabeled compounds are highlighted.
Trending and Emerging
- Targeted Alpha Therapy (TAT):
There is a growing interest in targeted alpha therapy, reflecting advancements in the understanding of radiobiology and the therapeutic potential of alpha-emitting isotopes for cancer treatment. - Artificial Intelligence in Imaging:
The integration of artificial intelligence and machine learning techniques in imaging analysis and radiopharmaceutical development is rapidly emerging as a key focus area. - Bioconjugation Techniques:
Research on bioconjugation strategies for enhancing the delivery and efficacy of radiopharmaceuticals is trending, particularly in the context of antibody-drug conjugates. - Immuno-PET Imaging:
The application of PET imaging with immunoconjugates for monitoring immune responses and cancer therapies is increasingly prominent, reflecting the growing field of immuno-oncology. - Nanoparticle-based Imaging and Therapy:
The use of nanoparticles for targeted imaging and therapy is gaining traction, with studies focusing on their unique properties for enhancing drug delivery and imaging sensitivity. - Radioligand Development for CNS Disorders:
There is an emerging trend in developing radioligands specifically for imaging central nervous system disorders, reflecting the need for better diagnostic tools in neurology.
Declining or Waning
- Traditional Radiopharmaceuticals:
There is a noticeable decline in studies focused on traditional radiopharmaceuticals, as newer, more targeted agents and approaches gain popularity. - Non-targeted Imaging Approaches:
Research on non-targeted imaging methods appears to be waning, as the field increasingly emphasizes precision medicine and targeted imaging agents. - Basic Radiochemistry:
Papers focusing exclusively on basic radiochemistry without applications in imaging or therapy are becoming less frequent, reflecting a trend towards more applied research. - Conventional SPECT Imaging:
The prevalence of conventional SPECT imaging studies has decreased, possibly due to the increasing adoption of PET and hybrid imaging techniques that offer higher sensitivity and resolution. - Invasive Procedures in Imaging:
Research involving invasive imaging procedures has diminished as the focus shifts towards less invasive and more patient-friendly imaging technologies.
Similar Journals
ANNALS OF NUCLEAR MEDICINE
Pioneering Insights for Nuclear Medicine ProfessionalsANNALS OF NUCLEAR MEDICINE is a prominent academic journal dedicated to the field of nuclear medicine, published by Springer. With a rich publication history dating back to 1987 and continuing through 2024, this journal serves as a vital resource for researchers and practitioners interested in the latest developments in nuclear imaging, radiopharmaceuticals, and therapeutic applications. Ranked in the second quartile (Q2) for both Medicine (miscellaneous) and Radiology, Nuclear Medicine, and Imaging categories in 2023, it maintains a strong position in the academic community, with an impressive Scopus rank of #104 out of 333 in its field, placing it in the 68th percentile. The journal is not open access but offers a range of access options through institutional or individual subscriptions, ensuring that critical research findings reach a wide audience. By fostering high-quality, peer-reviewed articles, ANNALS OF NUCLEAR MEDICINE plays a crucial role in advancing the understanding and practical application of nuclear medicine techniques, making it an essential journal for professionals and students aiming to stay at the forefront of this evolving discipline.
EJNMMI Research
Advancing the Frontiers of Nuclear Medicine and Imaging.EJNMMI Research, a prominent journal published by Springer, plays a pivotal role in advancing the fields of radiology, nuclear medicine, and imaging. With an impact factor that reflects its strong standing—ranking in the top 22% of its category (Q1 as of 2023)—this open-access journal offers researchers, professionals, and students unparalleled access to innovative research and developments in the field since its inception in 2011. Based in Germany, EJNMMI Research fosters global collaboration by ensuring that cutting-edge findings are freely accessible, thereby accelerating scientific discovery and application. With an emphasis on high-quality, peer-reviewed articles, it serves as an essential resource for those seeking to stay at the forefront of nuclear medicine and imaging. By bridging theoretical insights with practical applications, the journal not only influences academic discourse but also supports ongoing advancements in clinical practices.
Imaging
Pioneering Research in Radiology and BeyondImaging, published by AKADEMIAI KIADO ZRT, is an esteemed open-access journal dedicated to the field of medical imaging, established in 2020. With an E-ISSN of 2732-0960 and based in Budapest, Hungary, this journal provides a vital platform for the dissemination of cutting-edge research and advancements in imaging techniques, especially in the realms of radiology, nuclear medicine, and ultrasound technology. While currently positioned in the Q4 category across multiple medical specialties, the journal continues to strive for improvements in visibility and impact, contributing to the evolving discourse in medical imaging. The journal aims to facilitate an inclusive and collaborative environment for researchers, professionals, and students, inviting them to share their findings and insights to enhance the field's development. With open-access availability since its inception, Imaging ensures free and easy access to its content, fostering a greater understanding and appreciation of innovative imaging practices worldwide.
Hellenic Journal of Nuclear Medicine
Empowering Research and Innovation in Nuclear MedicineThe Hellenic Journal of Nuclear Medicine, published by the Hellenic Society of Nuclear Medicine, serves as a pivotal platform for researchers, professionals, and students in the fields of nuclear medicine, radiology, and imaging. Based in Greece and established as a prominent forum since 2004, this journal is dedicated to advancing the understanding and application of nuclear medicine through high-quality original research, reviews, and clinical studies. With an ISSN of 1108-1430 and an E-ISSN of 1790-5427, it has garnered attention within its community, holding a Q3 ranking in the 2023 category of Medicine (miscellaneous) and Radiology, Nuclear Medicine, and Imaging. Despite its current Scopus ranking of #235/333 in the respective fields, the journal is increasingly recognized for its potential to contribute impactful knowledge and innovations. Researchers are encouraged to utilize its resources to enhance their work and contribute to the growing body of knowledge in nuclear medicine. Notably, the journal maintains a commitment to accessible scholarly communication, fostering collaboration among experts across the globe.
Current Radiopharmaceuticals
Advancing the frontiers of radiopharmaceutical science.Current Radiopharmaceuticals, published by Bentham Science Publishers Ltd, is an esteemed journal dedicated to advancing the field of radiopharmaceuticals. With an ISSN of 1874-4710 and an E-ISSN of 1874-4729, this journal has been a significant platform for researchers since its inception in 2009, and will continue to contribute to the literature until at least 2024. Current Radiopharmaceuticals is recognized for its impactful contributions, holding a record of Q3 in Pharmacology and Q2 in Radiology, Nuclear Medicine, and Imaging as of 2023, illustrating its vital role in these domains. The journal aims to provide a comprehensive overview of the latest techniques, applications, and innovations within the field of radiopharmaceutical science, catering to a diverse audience of researchers, professionals, and students. Despite its significant contributions, the journal remains committed to enriching the academic community with high-quality, peer-reviewed articles that can be accessed worldwide, reflecting a dedication to open dialogue and knowledge dissemination in radiopharmaceutical research.
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Advancing the Frontiers of Nuclear Medicine and Imaging.The Quarterly Journal of Nuclear Medicine and Molecular Imaging, published by Edizioni Minerva Medica in Italy, serves as a pivotal platform for researchers and practitioners in the fields of Nuclear Medicine and Molecular Imaging. With an ISSN of 1824-4785 and an E-ISSN of 1827-1936, this journal boasts a respectable impact factor and is positioned in the Q3 quartile of the Radiology, Nuclear Medicine and Imaging category, based on the latest 2023 evaluations. As the journal continues to converge from its inception in 2004 to its anticipated expansions through 2024, it aims to disseminate high-quality, peer-reviewed articles that advance the frontier of imaging technologies and their applications in clinical practice. Researchers, professionals, and students are encouraged to contribute to its diverse scope, which encompasses innovative research, clinical findings, and reviews that encapsulate cutting-edge advancements in the field, highlighting its importance as an essential resource for knowledge and collaboration.
BMC MEDICAL IMAGING
Empowering Researchers and Clinicians in Medical Imaging.BMC Medical Imaging is a premier open-access journal dedicated to advancing the field of radiology, nuclear medicine, and imaging technologies. Published by BMC in the United Kingdom, this journal serves as a vital resource for researchers, clinicians, and students, fostering a collaborative environment for sharing innovative findings and methodologies in medical imaging. With a commendable impact factor and an impressive Scopus ranking within the top 35% of its category, BMC Medical Imaging provides a platform for high-quality research to be disseminated widely and freely since its inception in 2001. The journal aims to cover a diverse array of topics, from advanced imaging techniques to their clinical applications, enhancing the understanding and effectiveness of diagnostic practices. By contributing to the body of knowledge and facilitating open access to research, BMC Medical Imaging plays a pivotal role in shaping the future of medical imaging and improving patient care.
ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN
Advancing the Frontiers of Radiological ScienceROFO-Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, published by Georg Thieme Verlag KG, is a pivotal journal in the fields of radiology and nuclear medicine, offering invaluable insights for researchers, healthcare professionals, and students alike. With an ISSN of 1438-9029, this journal has been a stalwart of scientific communication since its inception in 1975, actively contributing to advancements in imaging techniques and radiation therapy. Although it operates under traditional access, the journal maintains a respectable standing, reflected by its Q3 ranking in Radiology, Nuclear Medicine and Imaging and Q4 in Medicine (miscellaneous), highlighting its significance in the scholarly community. Its coverage spans a wide array of topics pertinent to diagnostic imaging and therapy protocols, making it an essential resource for anyone seeking to understand the complexities of modern radiological practices. As the journal continues to evolve through 2024, it invites contributions that enrich the dialogue around technological innovations and clinical applications in the realm of imaging modalities.
Current Radiology Reports
Unlocking the future of imaging and nuclear medicine.Current Radiology Reports is an esteemed journal published by SPRINGERNATURE, focusing on the dynamic field of radiology, nuclear medicine, and imaging. With a commitment to advancing knowledge and promoting innovative practices, this journal serves as a valuable resource for researchers, healthcare professionals, and students striving to stay at the forefront of radiological advancements. Featuring an impressive impact factor and recognized as a Q3 journal within its category as of 2023, it highlights critical developments and comprehensive reviews that inform clinical practice and research methodologies. Although it operates under a subscription model, the journal provides a rich repository of peer-reviewed content, covering a wide range of topics from diagnostic imaging to therapeutic applications. With a publication span from 2013 to 2024, Current Radiology Reports continues to uphold its reputation as a leading publication critical for anyone involved in the radiology profession.
PET Clinics
Advancing the Frontiers of PET Imaging.PET Clinics, published by Elsevier Inc, is a premier academic journal focusing on the advancements and applications of Positron Emission Tomography (PET) in various medical fields. With its ISSN 1556-8598 and E-ISSN 1559-7814, the journal has established a strong reputation in the scientific community, reflected in its impressive Q1 quartile rankings in Medicine (miscellaneous), Radiation, and Radiology, Nuclear Medicine, and Imaging for 2023. The journal operates within a well-defined scope that bridges innovative research and practical clinical applications, targeting professionals, researchers, and students keen on the intersection of nuclear medicine and imaging technologies. Although not an open-access journal, PET Clinics ensures accessibility through institutional subscriptions, making valuable insights available to the academic community. With an emphasis on enhancing patient care and treatment outcomes through cutting-edge imaging techniques, this journal serves as an essential resource for those seeking to expand their knowledge and expertise in the rapidly evolving field of PET.